# Protagonist Therapeutics, Inc: Form 8-K, filed Jan 31, 2024

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: 8-K
- Filed: 2024-01-31
- Accepted by EDGAR: Jan 31, 2024, 16:05 ET
- Period: 2024-01-31
- Accession: 0001104659-24-008787
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465924008787/tm244678d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465924008787/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465924008787/tm244678d1_8k.htm

Filed Jan 31, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-008787. Last ingested by Listed: Nov 6, 2026, 12:26 ET. No prices; not investment advice.